China's economy managed a mixed economic performance in May, as retail sales jumped while factory output slowed in the face of higher U.S. tariffs.

In May, Pfizer spent $1.25 billion upfront for the right to license an experimental cancer drug from China's 3SBio. That is ...

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

Some of the popular products I'm watching for CNET's daily tariff price tracker are on sale so now might be the time to take ...

The said tariffs will prompt Chinese home appliance manufacturers and exporters to realign supply chain networks and ...

U.S. Senator Elizabeth Warren wrote a letter to outline the "terrible track record" of the Trump Administration's enforcement ...

The US has reached a new trade agreement with China under which all Chinese imports will face a 55% tariff, while American ...

Both countries say they have a "framework" that basically gets trade talks back to the agreement they made in Geneva a month ago.

The potential stunting of innovation follows an economic slowdown during the coronavirus pandemic, when companies also had to ...

IMF spokesperson Julie Kozack said that since the last release of the Fund's World Economic Outlook in April, there have been ...

What is the biggest US crypto news today? JPMorgan says an attack on Iran could spike oil prices to $120, driving US CPI ...

The major averages posted modest gains on Thursday, catching a tailwind from a cooler-than-anticipated inflation report.